[1]
Bjarnason, G.A. 2016. Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?. Canadian Urological Association Journal. 10, 11-12 (Dec. 2016), S252–5. DOI:https://doi.org/10.5489/cuaj.4293.